ursolic acid and Granulocytic Leukemia, Chronic
ursolic acid has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chi, ZF; Hu, R; Liu, ZG; Wang, X; Wu, B; Yang, W; Zhang, R | 1 |
Cipak, L; Grausova, L; Miadokova, E; Novotny, L; Rauko, P | 1 |
Other Studies
2 other study(ies) available for ursolic acid and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Proliferation; Cytochromes c; Dose-Response Relationship, Drug; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Time Factors; Triterpenes; Up-Regulation; Ursolic Acid | 2012 |
Dual activity of triterpenoids: apoptotic versus antidifferentiation effects.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Doxorubicin; Drug Combinations; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Oleanolic Acid; Triterpenes; Ursolic Acid | 2006 |